公开(公告)号：US10195258B2

公开(公告)日：2019-02-05

申请号：US14166954

申请日：2014-01-29

Applicant: NITTO DENKO CORPORATION ,  OSAKA UNIVERSITY

Inventor： Yoshiki Maeda ,  Katsuyuki Okubo ,  Daisuke Asari ,  Arimichi Okazaki ,  Takuya Shishido ,  Mitsuhiko Hori ,  Haruo Sugiyama

IPC: A61K39/00 ,  A61K9/70

Abstract: The present invention provides a cancer vaccine tape preparation for inducing cellular immunity, comprising: a support, an adhesive layer comprising an adhesive disposed on one side of the support, wherein the adhesive layer carries a combination of: (i) a WT1 peptide and/or a modified WT1 peptide; and (ii) a first cellular immunity induction promoter. The tape preparation can provides high efficacy.

公开(公告)号：US10206985B2

公开(公告)日：2019-02-19

申请号：US14166970

申请日：2014-01-29

Applicant: NITTO DENKO CORPORATION ,  OSAKA UNIVERSITY

Inventor： Daisuke Asari ,  Kyohei Matsushita ,  Arimichi Okazaki ,  Yoshiki Maeda ,  Katsuyuki Okubo ,  Mitsuhiko Hori ,  Haruo Sugiyama

IPC: A61K39/00 ,  A61K9/00

Abstract: The present invention provides a cancer vaccine composition for mucosal administration for inducing cellular immunity, comprising (i) a WT1 peptide and/or a modified WT1 peptide; and (ii) a cellular immunity induction promoter. The composition efficiently induces cellular immunity against a cancer in a subject.

公开(公告)号：US10449144B2

公开(公告)日：2019-10-22

申请号：US14166932

申请日：2014-01-29

Applicant: NITTO DENKO CORPORATION ,  OSAKA UNIVERSITY

Inventor： Katsuyuki Okubo ,  Yoshiki Maeda ,  Arimichi Okazaki ,  Daisuke Asari ,  Takuya Shishido ,  Mitsuhiko Hori ,  Haruo Sugiyama

IPC: A61K9/00 ,  A61K38/10 ,  A61K39/00

Abstract: The present invention provides a cancer vaccine composition for transdermal administration for inducing cellular immunity, comprising (i) a WT1 peptide and/or a modified WT1 peptide; and (ii) a cellular immunity induction promoter. The composition efficiently induces cellular immunity against a cancer in a subject.

公开(公告)号：US10071051B2

公开(公告)日：2018-09-11

申请号：US14166950

申请日：2014-01-29

Applicant: NITTO DENKO CORPORATION ,  OSAKA UNIVERSITY

Inventor： Katsuyuki Okubo ,  Yoshiki Maeda ,  Arimichi Okazaki ,  Daisuke Asari ,  Takuya Shishido ,  Mitsuhiko Hori ,  Haruo Sugiyama

IPC: A61K9/00 ,  A61K38/10 ,  A61K39/00 ,  A61K31/045 ,  A61K31/437 ,  A61K31/451 ,  A61K31/513 ,  A61K31/708 ,  A61K31/716 ,  A61K31/728 ,  A61K31/739

CPC classification number: A61K9/0014 ,  A61K31/045 ,  A61K31/437 ,  A61K31/451 ,  A61K31/513 ,  A61K31/708 ,  A61K31/716 ,  A61K31/728 ,  A61K31/739 ,  A61K38/10 ,  A61K39/0011 ,  A61K2039/54

Abstract: The present invention provides a cancer vaccine composition for transdermal administration for cellular immunity induction, comprising (i) a WT1 peptide and/or a modified WT1 peptide; and (ii) a pharmacologically acceptable acid as a first cellular immunity induction promoter, or a pharmacologically acceptable salt thereof.

公开(公告)号：US10076491B2

公开(公告)日：2018-09-18

申请号：US14166965

申请日：2014-01-29

Applicant: NITTO DENKO CORPORATION

Inventor： Daisuke Asari ,  Katsuyuki Okubo ,  Takuya Shishido ,  Arimichi Okazaki ,  Yoshiki Maeda ,  Kyohei Matsushita ,  Wenjing Li ,  Mitsuhiko Hori ,  Haruo Sugiyama

IPC: A61K39/00 ,  A61K39/02 ,  A61K45/06 ,  A01N63/00 ,  A61K31/7004 ,  A61K9/00 ,  A61K31/407 ,  A61K31/192 ,  A61K31/405 ,  A61K31/616 ,  A61K31/196 ,  A61K31/415 ,  A61K31/42 ,  A61K31/4035 ,  A61K31/353 ,  A61K31/5575 ,  A61K31/216 ,  A61K31/426 ,  A61K38/10 ,  A61K39/39

CPC classification number: A61K9/0014 ,  A61K31/192 ,  A61K31/196 ,  A61K31/216 ,  A61K31/353 ,  A61K31/4035 ,  A61K31/405 ,  A61K31/407 ,  A61K31/415 ,  A61K31/42 ,  A61K31/426 ,  A61K31/5575 ,  A61K31/616 ,  A61K38/10 ,  A61K39/0011 ,  A61K39/39 ,  A61K2039/54 ,  A61K2039/572

Abstract: The invention provides a vaccine composition containing an antigen for inducing cellular immunity, comprising at least one first cellular immunity induction promoter.